Valneva lost UK approval, but it had already stopped distributing the vaccine there after sluggish traveler sales. No UK stock remains for recall, and approvals elsewhere remain, so current operations change little.
Valneva had already stopped UK sales after sluggish traveler demand. It expects no recall costs, and approvals elsewhere remain. The UK loss removes permission to sell there, but does not change current operations.
Follow Valneva SE (VALN) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for VALN